Surface Pharmaceuticals
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- $41M
Investors
- 2
About Surface Pharmaceuticals
Surface Pharmaceuticals, Inc.Founded in 2017, Surface Pharmaceuticals, Inc. operates from its headquarters in San Diego, US. The company specializes in addressing dry eye syndrome through a focused approach on product development and commercialization.Surface Ophthalmics® develops and commercializes treatments for dry eye syndrome (DES), offering a pipeline of prescription and over-the-counter eye drops designed to restore tear film homeostasis.Surface Ophthalmics® generates revenue primarily through direct sales of its eye drop products to eyecare professionals and retail partnerships. The company engages with ECPs who prescribe or recommend its treatments, which are then available for purchase at pharmacies and specialty eye care outlets.Looking ahead, Surface Pharmaceuticals, Inc. The company is also targeting expansion into additional geographic regions, although specific markets and timelines have not been outlined.
Who invested in Surface Pharmaceuticals
2 investors across 2 rounds
See all investors in Surface Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Surface Pharmaceuticals
Who invested in Surface Pharmaceuticals?
Surface Pharmaceuticals has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Surface Pharmaceuticals raised?
Surface Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Surface Pharmaceuticals last raise money?
Surface Pharmaceuticals's most recent round on record is a Series A, in Jul 2018.
What does Surface Pharmaceuticals do?
Surface Pharmaceuticals is a pharmaceuticals company.
Where is Surface Pharmaceuticals headquartered?
Surface Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Surface Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Surface Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Surface Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.